Medical affairs teams are being asked to move faster than ever. New drug launches, acquisitions, and regulatory updates don’t wait for IT change orders. Neither do patients.
This guide examines what’s holding most grantmaking programs back, and what it looks like when the infrastructure finally matches the ambition. Featuring real-world examples from industry leaders Sanofi and Novartis, it’s a grounded look at how modern grantmaking technology helps teams adapt faster, document better, and reach further.
